Insider Trading activities of Regenerx Biopharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regenerx Biopharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regenerx Biopharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Regenerx Biopharmaceuticals Inc since 2005. The reporting company's ticker symbol is RGN. The reporting company's CIK number is 707511.
The total value of stock buying since 2005 is $58,597,197.
The total value of stock sales since 2005 is $952,000.
The total value of stock option exercises since 2005 is $58,624.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Regenerx Biopharmaceuticals Inc (RGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-01 6,666,668 $1,799,999 0 $0 0 $0
2010-06 20,000 $5,679 0 $0 0 $0
2010-05 240,000 $0 0 $0 0 $0
2009-10 2,439,024 $1,999,998 0 $0 0 $0
2009-06 1,250,000 $500,000 625,000 $250,000 0 $0
2009-04 2,105,262 $1,199,998 0 $0 0 $0
2008-12 3,103,446 $4,499,994 0 $0 0 $0
2008-02 5,000,000 $5,000,000 0 $0 0 $0
2007-09 5,000 $7,825 0 $0 0 $0
2007-03 0 $0 0 $0 165,000 $16,500
2006-12 4,166,665 $7,499,995 0 $0 0 $0
2006-07 0 $0 0 $0 26,316 $39,474
2006-05 125,000 $350,000 125,000 $350,000 0 $0
2006-03 2,324,700 $6,532,406 0 $0 0 $0
2005-08 110,000 $352,000 0 $0 0 $0
2005-06 12,597,765 $28,849,303 110,000 $352,000 0 $0
2005-05 0 $0 0 $0 5,000 $2,650

Table 2. Detailed insider stock purchases, sales, and option exercises of Regenerx Biopharmaceuticals Inc insiders (RGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-01-05 Sinaf S.a. Buy 1,296,297 .27 350,000
2011-01-05 Defiante Farmaceutica Lda Buy 925,926 .27 250,000
2011-01-05 Cavazza Claudio Buy 2,222,222 .27 599,999
2011-01-05 Cavazza Paolo Buy 2,222,223 .27 600,000
2010-06-11 Lyons C Neil (CFO & Treasurer) Buy 15,000 .28 4,260
2010-06-10 Lyons C Neil (CFO & Treasurer) Buy 5,000 .28 1,419
2010-05-21 Cavazza Paolo Buy 240,000 .00 0
2009-10-08 Chaumiere Consultadoria & Servicos Sdc Unipessoal Buy 1,219,512 .82 999,999
2009-10-08 Cavazza Paolo Buy 1,219,512 .82 999,999
2009-06-02 Inverlochy Consultadoria & Servicos L.d.a. Buy 312,500 .40 125,000
2009-06-02 Chaumiere Consultadoria & Servicos Sdc Unipessoal Buy 312,500 .40 125,000
2009-06-02 Cavazza Claudio Buy 312,500 .40 125,000
2009-06-02 Cavazza Paolo Buy 312,500 .40 125,000
2009-06-02 Hindin Richard J (Director) Sale 625,000 .40 250,000
2009-04-13 Chaumiere Consultadoria & Servicos Sdc Unipessoal Buy 1,052,631 .57 599,999
2009-04-13 Cavazza Paolo Buy 1,052,631 .57 599,999
2008-12-10 Chaumiere Consultadoria & Servicos Sdc Unipessoal Buy 1,034,482 1.45 1,499,998
2008-12-10 Cavazza Claudio Buy 1,034,482 1.45 1,499,998
2008-12-10 Cavazza Paolo Buy 1,034,482 1.45 1,499,998
2008-02-29 Cavazza Claudio Buy 2,500,000 1.00 2,500,000
2008-02-29 Cavazza Paolo Buy 2,500,000 1.00 2,500,000
2007-09-06 Finkelstein J J (President and CEO) Buy 5,000 1.56 7,825
2007-03-12 Mcnay Joseph C (Director) Option Ex 165,000 .10 16,500
2006-12-21 Defiante Farmaceutica Lda Buy 833,333 1.80 1,499,999
2006-12-21 Cavazza Claudio Buy 1,666,666 1.80 2,999,998
2006-12-21 Cavazza Paolo Buy 1,666,666 1.80 2,999,998
2006-07-17 Mcnay Joseph C (Director) Option Ex 26,316 1.50 39,474
2006-05-26 Cavazza Paolo Buy 125,000 2.80 350,000
2006-05-26 Finkelstein J J (President and CEO) Sale 125,000 2.80 350,000
2006-03-06 Defiante Farmaceutica Lda Buy 731,850 2.81 2,056,498
2006-03-06 Cavazza Claudio Buy 796,425 2.81 2,237,954
2006-03-06 Cavazza Paolo Buy 796,425 2.81 2,237,954
2005-08-01 Cavazza Paolo (10% Owner) Buy 110,000 3.20 352,000
2005-06-22 Defiante Farmaceutica Lda (10% Owner) Buy 307,692 3.25 999,999
2005-06-22 Cavazza Claudio (10% Owner) Buy 5,837,344 2.27 13,227,421
2005-06-22 Cavazza Paolo (10% Owner) Buy 6,452,729 2.27 14,621,883
2005-06-20 Goldstein Allan L (Director) Sale 110,000 3.20 352,000
2005-05-01 Mcnay Joseph C (Director) Option Ex 5,000 .53 2,650

Insider trading activities including stock purchases, stock sales, and option exercises of RGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regenerx Biopharmaceuticals Inc (symbol RGN, CIK number 707511) see the Securities and Exchange Commission (SEC) website.